‘I am not dead yet': Woman in China falls from 12th floor, calls husband for help from ground
In a shocking incident in southeastern China, a 44-year-old woman survived a fall from the 12th floor and even managed to call out to her husband for help after hitting the ground. The extraordinary story of Peng Huifang, a factory cleaner from Leping in Jiangxi province, has captured nationwide attention for her miraculous survival, reported the South China Morning Post.
Also read: South Korean mother reunites with abducted daughter after 44 years, now suing government over illegal adoption
The incident occurred on May 13 when Peng was assisting her husband, who runs a window business, in sealing a client's balcony. Thinking she was in a safe spot indoors and away from the balcony, she skipped wearing a safety rope, a move that nearly turned fatal.
While using a crane to lift a heavy window, estimated to weigh several hundred kilograms, to the 12th floor, the glass panel reportedly got caught on a tree branch. The snag caused the window to fall, dragging the crane along with it. Peng, who was holding the crane's remote control, was pulled out of the building.
'All I could think was, 'I am going to die, I am leaving this world forever',' Peng recalled.
Her life was saved by an awning that broke her fall and absorbed much of the impact before she landed on the ground. Though she couldn't move, Peng said she felt no pain and managed to alert her husband.
'I am not dead yet, call 120!' she shouted.
Peng was quickly taken to the Second Affiliated Hospital of Nanchang University, where doctors performed surgery to treat multiple fractures, including injuries to her right foot, left leg, and lower back. Fortunately, her upper body remained mostly unharmed. Doctors are optimistic she could regain full mobility within six months.
Speaking from the hospital, Peng expressed remorse for not wearing a safety harness and urged others not to take workplace safety lightly. She also said she did not blame the client nor plan to seek any compensation.
'The fall was entirely due to our failure to operate the equipment correctly. It had nothing to do with the client,' she said. 'In fact, we felt quite embarrassed to have inconvenienced them.'
Also read: 'Spookiest s**t ever': AI blackmails engineer over affair after being told it'll be replaced
The family has already spent over 70,000 yuan (US$10,000) on medical expenses and is currently seeking help to cover the cost of further treatment.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
4 hours ago
- Time of India
Sexagenarian South Korea man sets fire in Seoul subway as he was angry at divorce suit outcome
An apprehended arson suspect in his 60s is believed to have told police that he set fire inside a Seoul subway train on Saturday as he was angry at the outcome of a divorce lawsuit. The suspect allegedly set fire to pieces of clothes inside the Line Number 5 subway travelling between the Yeouinaru and Mapo stations at 8:43 a.m. after boarding the train with a lighter-type torch and a fuel container, according to police and witnesses, as per a report. During an investigation by police, the suspect is believed to have stated he set the fire in complaint about the outcome of a divorce lawsuit. The suspect reportedly had no intent to kill himself, IANS reported. Police found the suspect had a lot of soot on his hands when he was carried out on a stretcher from the platform at Yeouinaru Station. He was apprehended at the scene at 9:45 a.m. after admitting to the alleged arson during police questioning. Police plan to file a formal arrest warrant against him on Sunday, Yonhap news agency reported. Due to the fire, more than 400 passengers escaped through the tunnel, with 21 of them being sent to the hospital for injuries, such as smoke inhalation and a fractured ankle. No serious injuries have so far been reported. Live Events Passengers and the train conductor initially contained the flames with fire extinguishers before they were fully extinguished at about 10:24 a.m. Authorities dispatched 230 personnel, including firefighters and police officers, to the scene. Subway services between Yeouido and Aeogae stations were suspended for a while before resuming at 10:06 a.m. Earlier in the day, South Korean Police apprehended the accused. Police questioned the suspect about the motive and conducted a forensic examination of the scene. FAQs Q1. Which city is capital of South Korea ? A1. Capital of South Korea is Seoul. Q2. Name any station located at Seoul subway? A2. Stations located at Seoul subway are Yeouido and Aeogae.
United News of India
7 hours ago
- United News of India
Myanmar authorities seize 2 million stimulant tablets, 134 kg of heroin in massive drug bust
Naypyidaw, May 31 (UNI) Myanmar authorities have seized nearly two million stimulant tablets and over 134 kg of heroin in one of the country's largest recent drug busts, valued at about US $3 million), according to a statement released by the Myanmar Police Force. Acting on tip-off, the operation unfolded late on May 20 in Lewe Township. Led by a joint team from the Drug Enforcement Division, the authorities stopped a Fuso 12-wheel truck late on May 20 as it travelled from Aungnangcho to Pyinmana, reports Global Light of Myanmar. The truck, driven by Zin Myo Htet Aung (aka Kala Lay) and accompanied by Min Khant Kyaw and Myat Soe Oo (aka Super), was found to be carrying 1,999,400 methamphetamine pills and 134.2 kilograms of heroin. Simultaneously, two Chevrolets believed to be escort vehicles were also intercepted. Drivers Thurein Ko Ko, along with Kyaw Myo Hlaing (aka Kyaw Gyi) and Nay Oo Shein, were taken into custody. The investigation led to further arrests the next morning. At a hotel in Pyinmana Township, police apprehended Paw Lu (aka Paw Lu Chan), Soe Lwin, and Thein San Htun (aka Kala Lay), believed to be key figures in a trafficking network moving drugs from Shan State to Mandalay. Legal proceedings have begun for those arrested, with the police stating that efforts are underway to identify and detain additional individuals involved in the massive trafficking operation. This latest seizure follows a similar bust in Shan State just days earlier, where authorities confiscated 500,000 stimulant tablets worth over K200 million (approximately USD $93,000). Myanmar – a central hub in the 'Golden Triangle' -- has long been a major conduit for drug smuggling operations across South East Asia. The network, which converges on the country's borders with Laos, and Thailand, is infamous for being one of the most prolific global epicentres for the manufacture and distribution of heroin, and more recently, methamphetamine. Despite repeated crackdowns, organised trafficking networks continue to thrive with billions in illicit profits, and a deeply entrenched infrastructure. UNI ANV PRS
New Indian Express
7 hours ago
- New Indian Express
Sun Pharma's Checkpoint buy: Why it's a strategic fit in the new SPIL focus
CHENNAI: India's largest drug maker, Sun Pharmaceutical Industries, has completed its acquisition of US-based Checkpoint Therapeutics for approximately $355 million. This strategic move significantly strengthens Sun Pharma's oncology and dermatology portfolio, aligning with its focus on high-value specialty therapies. Despite the long-term strategic value, the market reaction on Friday surprised many, as Sun Pharma's share price fell by 1.46% at the close of the week's trading. This dip may have been driven by immediate concerns, including regulatory issues at a key manufacturing facility and the company's cautious financial guidance. Investors are closely monitoring developments—particularly the US FDA's observations regarding Sun Pharma's Dahej facility. The company's financial performance in the coming quarters will also be under scrutiny as stakeholders assess the potential impact on its stock trajectory. Strategic Rationale and Synergies of the Checkpoint Deal Drug industry analysts believe the Checkpoint acquisition is a major strategic gain for Sun Pharma, which has historically grown through carefully chosen, high-potential acquisitions. According to analysts at HDFC Securities, the deal aligns with Sun Pharma's capital allocation strategy to strengthen its specialty business. Checkpoint's Unloxcyt—a novel skin cancer drug—will serve as a complementary addition to its oncology portfolio. In the post-Q4 earnings call, Chairman and Managing Director Dilip Shanghvi reiterated the company's commitment to expanding its specialty business. Sun Pharma's specialty and innovative therapeutics division currently focuses on dermatology, ophthalmology, and oncology. Unloxcyt will complement existing products such as Odomzo (sonidegib) and Yonsa (abiraterone acetate)—both approved in the US—Nidlegy (awaiting approval in the EU), and the recently acquired Fibromun (in Phase III trials). Other specialty molecules in development, including Ilumya (for psoriatic arthritis), GL0034 (obesity), MM-II (osteoarthritis), SCD-044 (atopic dermatitis/psoriasis), and Fibromun (for soft tissue sarcoma/glioblastoma), offer long-term growth potential. According to analysts, the Checkpoint acquisition is strategically significant for four key reasons:
